What are the recommended dosing, contraindications, and monitoring guidelines for ketamine use in prehospital emergency care for adults and children?

Ketamine in Prehospital Emergency Care

Ketamine is a safe and effective agent for prehospital procedural sedation and analgesia, particularly in children, and should be administered at 1-2 mg/kg IV (over 60 seconds) or 4-5 mg/kg IM for adults, with pediatric dosing at 1.5 mg/kg IV or 4-5 mg/kg IM. 1, 2

Recommended Dosing

Adults

• IV route: 1-4.5 mg/kg administered slowly over 60 seconds; typical dose is 2 mg/kg for 5-10 minutes of surgical anesthesia 2
• IM route: 6.5-13 mg/kg; typical dose is 9-13 mg/kg producing anesthesia within 3-4 minutes lasting 12-25 minutes 2
• Maintenance: Repeat increments of one-half to full induction dose as needed 2
• For agitation/combativeness: 4 mg/kg IM has been used successfully in prehospital settings 3

Pediatrics

• IV route: 1.5 mg/kg bolus produces adequate sedation in 94% of children 1
• IM route: 4-5 mg/kg intramuscularly 1
• The American College of Emergency Physicians provides Level A evidence that ketamine can be safely administered to children for procedural sedation and analgesia 1

Combination Therapy

• With midazolam: 0.07 mg/kg IV midazolam followed by 2 mg/kg IV ketamine provides effective sedation in adults 1
• Consider administering 2 mg midazolam (median dose for 70 kg adult) to prevent emergence reactions 4
• With fentanyl: Combination is effective but requires careful monitoring as combined benzodiazepines and opioids increase respiratory compromise risk 1

Contraindications

Absolute Contraindications

• Significant elevation of blood pressure would be a serious hazard (e.g., uncontrolled hypertension, acute coronary syndrome with severe hypertension, intracranial hemorrhage) 2
• Known hypersensitivity to ketamine or excipients 2

Relative Contraindications

• Procedures of the pharynx, larynx, or bronchial tree when used as sole agent (pharyngeal and laryngeal reflexes are not suppressed; muscle relaxants may be required) 2
• Patients who have not followed nil per os guidelines (due to vomiting and aspiration risk) 2

Important caveat: Knowledge of ketamine contraindications among prehospital providers has been documented as poor, requiring improved education 4

Monitoring Guidelines

Essential Monitoring

• Continuous vital signs monitoring during administration 2
• Pulse oximetry should be used, particularly in patients at increased risk of hypoxemia (high doses, multiple drugs, significant comorbidity) 1
• Emergency airway equipment must be immediately available 2
• Consider capnometry for early identification of hypoventilation 1

Personnel Requirements

• Must be administered by or under direction of physicians experienced in general anesthetics, airway maintenance, oxygenation, and ventilation 2
• In prehospital settings, trained paramedics following specific protocols can safely administer ketamine 5, 3

Common Pitfall

Documentation of full monitoring sets occurred in only 27.8% of prehospital cases in one study, indicating a significant gap between guidelines and practice 6

Safety Profile and Adverse Events

Most Common Adverse Events

• Emergence reactions: Postoperative confusional states during recovery; minimize by reducing verbal, tactile, and visual stimulation 2
• Hallucinations: Most commonly reported adverse event in prehospital use 4
• Elevated blood pressure and pulse: Expected pharmacologic effect 2
• Hypersalivation: Administer antisialagogue prior to induction 2

Respiratory Effects

• Respiratory depression may occur with overdosage or too rapid administration; maintain adequate oxygenation and ventilation 2
• Ketamine preserves protective airway reflexes better than other sedatives, though vomiting and aspiration remain possible 2
• In pediatric studies, no episodes requiring intubation were reported despite 1.4% experiencing airway complications (laryngospasm, apnea, respiratory depression) 1

Serious Considerations

• Pediatric neurotoxicity: Long-term cognitive deficits may occur when used for longer than 3 hours in children ≤3 years 2
• Genitourinary pain: Case reports exist in chronic ketamine users; consider cessation if genitourinary pain continues 2

Clinical Applications in Prehospital Settings

Primary Indications

• Acute analgesia during painful procedures (fracture manipulation, extrication) 4, 6
• Hypotension with need for analgesia (ketamine maintains hemodynamic stability unlike opioids) 5
• Agitation or combativeness with intact airway 5, 3
• Pain unresponsive to narcotic medications 5
• Benzodiazepine-resistant status epilepticus: 100 mg IV/IO/IM/intranasal in adults; 1 mg/kg IM/intranasal in children terminated seizures in 98.2% of adults without recurrence 7

Practical Advantages

• Can be administered IM without IV access 5, 3
• Rapid onset: IV within 30 seconds, IM within 3-4 minutes 2
• Maintains respiratory drive and airway reflexes better than other sedatives 5
• No reversal agent needed (unlike opioids) 5

Administration Technique

• Slow IV administration is critical: Over 60 seconds to prevent respiratory depression and enhanced vasopressor response 2
• Do not administer 100 mg/mL concentration IV without proper dilution: Dilute with equal volume of sterile water, normal saline, or D5W; use immediately after dilution 2
• Intranasal delivery: Enhanced with atomizer for better mucosal distribution 8

Special Populations

Children with Developmental Disabilities

• Require additional assessment strategies using parental understanding of subtle behavioral changes 8
• Myths of pain insensitivity must be actively avoided 8
• Child life specialists can assist with coping strategies 8

Trauma Patients

• Particularly useful when hypotension precludes opioid use 5
• No adverse sequelae associated with comorbid factors including head trauma 1

Evidence Quality Summary

The strongest evidence supports ketamine use in pediatric procedural sedation (Level A recommendation from ACEP guidelines) 1. Adult use is supported by Level B evidence showing safety when combined with midazolam 1. Prehospital studies demonstrate consistent safety across multiple settings 5, 6, 3, though most are observational rather than randomized controlled trials. The 2024 study on benzodiazepine-resistant status epilepticus provides the most recent high-quality evidence for this specific indication 7.